152 related articles for article (PubMed ID: 31368850)
1. Resequencing
Manoharan A; Shewade DG; Ravindranath PA; Rajkumar RP; Ramprasad VL; Adithan S; Damodaran SE
Pharmacogenomics; 2019 Jul; 20(10):719-729. PubMed ID: 31368850
[No Abstract] [Full Text] [Related]
2. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 Genetic Polymorphisms and Phenotypes in Different Ethnicities of Malaysian Breast Cancer Patients.
Chin FW; Chan SC; Abdul Rahman S; Noor Akmal S; Rosli R
Breast J; 2016; 22(1):54-62. PubMed ID: 26510986
[TBL] [Abstract][Full Text] [Related]
4. Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese population.
Fukunaga K; Hishinuma E; Hiratsuka M; Kato K; Okusaka T; Saito T; Ikeda M; Yoshida T; Zembutsu H; Iwata N; Mushiroda T
J Hum Genet; 2021 Feb; 66(2):139-149. PubMed ID: 32759992
[TBL] [Abstract][Full Text] [Related]
5. Genotype and allele frequency of CYP2D6 in Tamilian population.
Adithan C; Gerard N; Naveen AT; Koumaravelou K; Shashindran CH; Krishnamoorthy R
Eur J Clin Pharmacol; 2003 Oct; 59(7):517-20. PubMed ID: 12942225
[TBL] [Abstract][Full Text] [Related]
6. Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population.
Rideg O; Háber A; Botz L; Szücs F; Várnai R; Miseta A; Kovács GL
Cell Biochem Funct; 2011 Oct; 29(7):562-8. PubMed ID: 21826689
[TBL] [Abstract][Full Text] [Related]
7. Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population.
Salyakina D; Roy S; Wang W; Oliva M; Akhouri R; Sotto I; Mulas N; Solano R; Fernández JR; Sanchez S; Shamshad U; Perlyn C; McCafferty-Fernandez J
Mol Genet Genomic Med; 2019 Sep; 7(9):e922. PubMed ID: 31389673
[TBL] [Abstract][Full Text] [Related]
8. Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity.
Dalton R; Lee SB; Claw KG; Prasad B; Phillips BR; Shen DD; Wong LH; Fade M; McDonald MG; Dunham MJ; Fowler DM; Rettie AE; Schuetz E; Thornton TA; Nickerson DA; Gaedigk A; Thummel KE; Woodahl EL
Clin Transl Sci; 2020 Jan; 13(1):147-156. PubMed ID: 31536170
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 genetic polymorphism in South Indian populations.
Naveen AT; Adithan C; Soya SS; Gerard N; Krishnamoorthy R
Biol Pharm Bull; 2006 Aug; 29(8):1655-8. PubMed ID: 16880622
[TBL] [Abstract][Full Text] [Related]
10. Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis.
Nishimura M; Ueda M; Saruwatari J; Nakashima H; Ogusu N; Aoki A; Tsuchimine S; Matsuda K; Iwashita K; Ono T; Oniki K; Shimoda K; Yasui-Furukori N
Pharmacogenet Genomics; 2016 Sep; 26(9):403-13. PubMed ID: 27187662
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese.
Zhou Q; Yu XM; Lin HB; Wang L; Yun QZ; Hu SN; Wang DM
Pharmacogenomics J; 2009 Dec; 9(6):380-94. PubMed ID: 19636337
[TBL] [Abstract][Full Text] [Related]
12. Full-gene haplotypes refine CYP2D6 metabolizer phenotype inferences.
Wendt FR; Sajantila A; Moura-Neto RS; Woerner AE; Budowle B
Int J Legal Med; 2018 Jul; 132(4):1007-1024. PubMed ID: 29075918
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of the CYP2D6 gene among Malays in Malaysia.
Teh LK; Ismail R; Yusoff R; Hussein A; Isa MN; Rahman AR
J Clin Pharm Ther; 2001 Jun; 26(3):205-11. PubMed ID: 11422605
[TBL] [Abstract][Full Text] [Related]
14. Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population.
Roh HK; Dahl ML; Johansson I; Ingelman-Sundberg M; Cha YN; Bertilsson L
Pharmacogenetics; 1996 Oct; 6(5):441-7. PubMed ID: 8946476
[TBL] [Abstract][Full Text] [Related]
15. Inference of the Genetic Polymorphisms of CYP2D6 in Six Subtribes of the Malaysian Orang Asli from Whole-Genome Sequencing Data.
Yu CY; Ang GY; Subramaniam V; Johari James R; Ahmad A; Abdul Rahman T; Mohd Nor F; Shaari SA; Teh LK; Salleh MZ
Genet Test Mol Biomarkers; 2017 Jul; 21(7):409-415. PubMed ID: 28525288
[TBL] [Abstract][Full Text] [Related]
16. CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.
Byeon JY; Kim YH; Lee CM; Kim SH; Chae WK; Jung EH; Choi CI; Jang CG; Lee SY; Bae JW; Lee YJ
Arch Pharm Res; 2018 Sep; 41(9):921-930. PubMed ID: 30191460
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans.
Lee SJ; Lee SS; Jung HJ; Kim HS; Park SJ; Yeo CW; Shin JG
Drug Metab Dispos; 2009 Jul; 37(7):1464-70. PubMed ID: 19364831
[TBL] [Abstract][Full Text] [Related]
18. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia.
Ismail R; Teh LK; Amir J; Alwi Z; Lopez CG
J Clin Pharm Ther; 2003 Aug; 28(4):279-84. PubMed ID: 12911679
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of cytochrome P450 enzymes in Asian populations: focus on CYP2D6.
Kitada M
Int J Clin Pharmacol Res; 2003; 23(1):31-5. PubMed ID: 14621071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
